Blocking Cancer Progression and Shrinking Tumors with Antibody-ligand Traps

LuZhe Sun will discuss TGFβ signaling during cancer progression and how researchers can target this pathway.

The Scientist Creative Services Team
Dec 4, 2020

FREE Webinar

Friday, December 18, 2020
2:30 - 4:00 PM, Eastern Time

Register Now

Antibody-ligand traps unleash potent immune responses by binding and blocking proteins that typically enhance cancer progression and spread, such as TGFβ. In this webinar from The Scientist, LuZhe Sun will describe how he uses these traps to control the cell cycle in rapidly dividing cancer cells, shrinking tumors in the process.

Topics to be covered

  • Using novel TGFβ-targeting antibody-ligand traps to block tumor-promoting activities and enhance anti-cancer therapy

Register Now

Meet the Speakers:

LuZhe Sun, PhD
Professor and Dielmann Chair in Oncology
Department of Cell Systems and Anatomy
Associate Director for Basic Research, The Mays Cancer Center
University of Texas Health Science Center at San Antonio

genomics.png